Home
2024 Retreat
Memories
Agenda
Think Pieces
Presentations
Attendees
2023 Retreat
Memories
Agenda
Think Pieces
2022 Retreat
Memories
2021 Retreat
Memories
Think Pieces
Agenda
Presentations
Attendees
Biographies
Suggested Packing List
2020 Retreat
Booklet
Biographies
Itinerary
Ray’s Retreat Recordings
Presentations
Think Pieces
Videos
Selfies
2019 Retreat
Memories
Booklet
Biographies
Itinerary
Think Pieces
Presentations
2018 Retreat
Memories
Booklet
Itinerary
Biographies
Presentations
Think Pieces
2017 Retreat
Memories
Itinerary
Booklet
Pharmaceutical Names: From Regulation to Clearance
Biographies
Presentations
2016 Retreat
Memories
Think Pieces
2015 Retreat
Memories
Itinerary
Think Pieces
2014 Retreat
Memories
Itinerary
Group Alumni Photo Gallery
Testimonials
Contact

Ray's Retreat

Home
2024 Retreat
Memories
Agenda
Think Pieces
Presentations
Attendees
2023 Retreat
Memories
Agenda
Think Pieces
2022 Retreat
Memories
2021 Retreat
Memories
Think Pieces
Agenda
Presentations
Attendees
Biographies
Suggested Packing List
2020 Retreat
Booklet
Biographies
Itinerary
Ray’s Retreat Recordings
Presentations
Think Pieces
Videos
Selfies
2019 Retreat
Memories
Booklet
Biographies
Itinerary
Think Pieces
Presentations
2018 Retreat
Memories
Booklet
Itinerary
Biographies
Presentations
Think Pieces
2017 Retreat
Memories
Itinerary
Booklet
Pharmaceutical Names: From Regulation to Clearance
Biographies
Presentations
2016 Retreat
Memories
Think Pieces
2015 Retreat
Memories
Itinerary
Think Pieces
2014 Retreat
Memories
Itinerary
Group Alumni Photo Gallery
Testimonials
Contact
  • 2020 Retreat
  • Booklet
  • Biographies
  • Itinerary
  • Ray’s Retreat Recordings
  • Presentations
  • Think Pieces
  • Videos
  • Selfies

Think Pieces

Wall Street Journal OpEd Piece, “Antitrust Can't Bust a Monopoly of Ideas,” Aug. 6, 2020 (Vivek Ramaswamy)

Forbes, “Biggest Biotech IPO of 2016 Is Launched by 31 Year Old,” Oct. 27, 2016 (Vivek Ramaswamy)

Forbes, “The Invention Machine: Cleveland Duo Churns Out Ideas Worth Billions,” February 12, 2014 (John Nottingham and John Spirk)

Troutman Pepper, “Bankruptcy Code 363 Sales Reemerge During Pandemic” (Deborah Kovsky-Apap)

Troutman Pepper, “Can Compliance Negate Intent? The Case for Continuously Customizing Compliance Programs” (Miranda Hooker and Allison DeLaurentis)

Troutman Pepper, “Clinical Diagnosis Of FDA’s Clinical Investigation Exclusivity Standard? Unreasonable” (N. Nicole Stakleff)

Troutman Pepper, “Identify Your Trade Secrets Now, Before It’s Too Late” (William M. Taylor)

            

Back to Top

Copyright © 2024   Privacy Policy  |  Terms & Conditions  |  Attorney Advertising